Med. praxi. 2023;20(1):10-16 | DOI: 10.36290/med.2023.001

Hereditary periodic fevers from the group of autoinflammatory diseases

MUDr. Jana Fráňová, MUDr. Marcel Schüller, Ph.D.
Centrum dětské revmatologie, Pediatrická klinika Fakultní nemocnice Brno a Lékařské fakulty Masarykovy univerzity Brno

Autoinflammatory diseases (AID) are a group of rare inflammatory diseases caused by the dysregulation of nonspecific immunity mechanisms. In the absence of an obvious cause, they result in spontaneous general and/or local manifestations of inflammatory activity. Typical autoinflammatory diseases include periodic fever syndromes. These include in our country prevailing periodic fever associated with aphthous stomatitis, pharyngitis and lymph node inflammation (PFAPA syndrome), in which the cause is multifactorial and the genetic cause has not yet been defined, as well as classic monogenic fevers, such as Hyper-IgD syndrome or Familial Mediterranean fever, with genetic mutations already known. Genetically linked fevers are suspected when there is a family history of febrile episodes, the onset of problems at an early age, but also when there are recurrent associated symptoms, such as skin, eye or joint symptoms. The main risk of untreated monogenic periodic fevers is the development of secondary amyloidosis. Early anti-inflammatory treatment can prevent the development of organ damage, including renal failure.

Keywords: autoinflammatory disease (AID), periodic fever syndrome.

Accepted: March 2, 2023; Published: March 13, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fráňová J, Schüller M. Hereditary periodic fevers from the group of autoinflammatory diseases. Med. praxi. 2023;20(1):10-16. doi: 10.36290/med.2023.001.
Download citation

References

  1. Petty RE, Laxer RM, Lindsley CB, et al. Textbook of Pediatric Rheumatology. Eighth edition. Elsevier. 2021; p. 525-543.
  2. Schüller M. Autoinflamatortní onemocnění. In: Němec P, et al. Revmatologie pro praxi. Praha: Grada; 2022; p. 700-714.
  3. Doležalová P, Dallos T, et al. Dětská revmatologie v praxi, Praha: Mladá fronta; 2019; p. 321-333.
  4. Kuemmerle­‑Deschner JB, Ozen S, et al. Development and Validation of Diagnostic Criteria for Cryopyrin Associated Periodic Syndromes. Arthritis Rheumatol. 2015;67 (suppl 10).
  5. Šedivá A. Imunodeficience se zvláštním zaměřením na periodické horečky (disertační práce). Ústav imunologie UK 2. LF a FN Motol; 2009.
  6. Ozen S, Demirkaya E, Erer B, et al. EULAR recommendations for the management of Familial Mediterranean Fever. Ann Rheum, DiS. 2016;75:644-51. Go to original source... Go to PubMed...
  7. Toplak N, Dolezalová P, Constantin T, et al. Periodic fever syndromes in Eastern and Central European countries: results of a pediatric multinational survey. Pediatr Rheumatol Online J. 2010;8:29. Go to original source...
  8. Król P, Doležalová P. Recidivující febrilie u dětí. Pediatr. praxi. 2013;14(4):221-224.
  9. Gattorno M, Hofer M, Federici S, et al. Classification criteria for autoinflammatory recurrent fevers. Ann Rheum, DiS. 2019 Aug;78(8):1025-1032. Go to original source... Go to PubMed...
  10. Gaggiano C, Rigante D, Sota J, et al. Treatment options for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children and adults: a narrative review. Clin Rheumatol. 2019 Jan;38(1):11-17. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.